Antiplasmin and antiserum
US4346029A · kind A · utility
8Cited by
3References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 22, 1979 |
| Grant date | Aug 24, 1982 |
| Priority date | — |
| Expiry date | Jan 22, 1999 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/83
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A newly isolated constituent of human blood plasma, called antiplasmin, is disclosed together with its isolation method. Further, the invention relates to antiplasmin, a newly isolated constituent of the human blood plasma and to its method of isolation. Further, an antiplasmin-antiserum together with its preparation and utilization, and a method of determining antiplasmin in blood samples are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.